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Summary
Objective: To find the prevalence of HIV infection and risk behaviors among injecting drug users
(IDUs) in Karachi, Pakistan.
Design: A cross-sectional study of IDUs conducted in Karachi, Pakistan from February through
June 1996.
Results: Ofthe242 IDUs,11(4%)refusedHIVtesting.One(0.4%;95%confidence interval (CI) = 0.37—
0.48%)wasHIVpositive.All subjectsweremale.Over thepast 6months47%hadengaged in receptive
needlesharing,38%hadperceivedachange intheirsocialnetwork,22%hadhadsexual intercourse,of
whomonly7%alwaysusedcondoms,andnonehadwashedtheir needleswithbleach.Youngerage (28
vs. 31 years; p = 0.01), younger age at first injection (25 vs. 28 years; p = 0.001), fewer years of
schooling (3 vs. 5 years; p = 0.001), lower monthly income ($70 vs. $80; p = 0.03), inhaling fumes of
heroin from a foil in the year before injecting (OR = 4.8; CI = 2.2—10.3), injecting first time with
heroin (OR = 3.6; CI = 1.2—12.6), having a temporary job (OR = 2.5; CI = 1.2—5.2), and a perceived
change in one’s social network (OR = 4.4; CI = 2.4—7.9) were all associated with receptive needle
sharing. IDUs who knew about HIV spread through contaminated needles were less likely to share
(OR = 0.4; CI 0.2—0.8). In the final logistic regressionmodel receptive needle sharingwas associated
with inhaling of fumes of heroin on a foil in the year prior to injecting (adjusted OR = 5.6; CI = 2.6—
12.0), a perceived change in one’s social network (adjusted OR = 4.0; CI = 2.2—7.4), and inversely
associated with age at first time of injection (b = 0.07; p = 0.002).
Conclusion: Background HIV prevalence was low among IDUs in Karachi despite high-risk behavior
in 1996. In order to control HIV transmission among IDUs in Pakistan, continual HIV surveillance with
well-coordinated and effective HIV risk reduction, and drug demand reduction programs need to be
implemented among drug users.
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HIV can spread rapidly among intravenous drug users (IDUs).
The multi-center drug injector study1 elucidated these
dynamics globally. HIV prevalence rose within a few months
from 0 to greater than 40% in New York,2 Bangkok,3 Manipur,
India,4 and Edinburgh, Scotland.5 IDUs that injected in
‘shooting galleries’, where a rented needle was re-used,
primarily contributed to rapid HIV spread in New York. In
Bangkok, individuals with an increasing number of sharing
partners, injecting with used needles kept by dealers, and
being incarcerated were more likely to seroconvert to HIV.
However, IDUs in Glasgow (Scotland), Lund (Sweden), Sydney
(Australia), Tacoma (Washington), Toronto (Ontario,
Canada), and Hong Kong escaped such rises in HIV and main-
tained a low prevalence of less than 5% despite high-risk
behavior being common. Des Jarlais et al. had identified
three common factors in these cities:6 (1) early intervention
during low HIV prevalence, (2) provision of sterile injection
equipment to IDUs, and (3) implementation of community
outreach programs. Some studies have found low prevalence
of HIV among IDUs who injected in closed HIV seronegative
groups, and those who were in monogamous sexual relation-
ships.7
Pakistan falls in the ‘golden crescent’ along with Afghani-
stan and Iran, notorious for drug production and trafficking.
Tribal belts in North Pakistan that are outside government
control have been known to harvest the poppy since ancient
times. Traditionally cannabis and opium have been the most
popular drugs. In the 1980s after the banning of opium
production and the promulgation of strict laws regarding
heroin and opium possession in Pakistan, poppy production
declined. Opium production shifted to Afghanistan and
further multiplied after the first Afghan war in 1990.8 Due
to the lucrative nature of the trade, it ran a parallel economy
of exports to rich Western countries from 1994—1996 equiva-
lent to 19.6% of Pakistan’s gross domestic product.9 Under
international pressure the Taliban enforced a ban on poppy
cultivation in 2000 leading to near eradication of poppy
cultivation in 2001. Since 2002, in the post-Taliban Afghani-
stan, opium production has resumed and is spreading, with an
estimated earning in 2003 of US$2.3 billion supplying two-
thirds of the world’s opium.10
The 1993 national survey in Pakistan estimated that there
were 2.7 million drug users using narcotic and psychotropic
substances out of a population of 125million.11 Injections and
pharmaceutical drugs are easily available without prescrip-
tion in Pakistan. The 1993 survey estimated 1.52 million
heroin addicts, though the 2000 national survey estimated
0.5 million heroin addicts in Pakistan.12 In the 1993 national
survey, injecting drug abuse was first reported in 1.8% of
addicts in Karachi, the largest city in Pakistan, with an
international air and seaport. Prior to our study in 1994, Baqi
et al.13 found an alarming 25% injecting drugs and 52%
engaging in receptive needle sharing in a mixed population
of drug addicts in Karachi. Fortunately none were HIV posi-
tive. A study in 1999 from Lahore of 200 injecting drug users
found that none of them were HIV positive but 89% were
hepatitis C virus (HCV) positive.14 Subsequent studies have
shown an increase in injecting among drug users in Pakistan
though HIV testing was not part of these studies. The 2000
national survey12 involving fourmajor cities found that 15% ofheroin users mainly injected while 31% had injected on at
least one occasion, among amixed population of drug addicts
with a variation found in the different cities (Karachi 55%,
Lahore 30%, Quetta 14%, and Peshawar 12%). A study con-
ducted in 2001 at detoxification centers in three cities
identified that overall, 15.2% of drug users had injected drugs
on at least one occasion (Quetta 18.7%; Rawalpindi 16.8%,
and Peshawar 7.1%).15 In another study of the same period a
higher prevalence of injecting drug use was seen among
Afghanis than Pakistanis in Quetta (18.8% vs. 12.3%).16 In
2002 in Karachi the majority of drug users (>80%) had made a
transition toward injecting.17
Pakistan recently had an outbreak of HIVamong IDUs in the
Sindh province. First, in the small town of Larkana in June of
2003, 9.3% of IDUs (17 of 183) were tested positive for HIV.18
In follow-up studies carried out in 2003 in harm reduction
drop-in centers in Karachi, one IDU from the Larkana out-
break was found to be HIV positive (0.6% of 160 tested).17
Further sero-surveillance from January to July of 2004 in
Karachi identified 160 HIV positive IDUs.19 Surveillance data
from the Sindh AIDS control program has shown that up until
December of 2004 HIV prevalence among IDUs was 8.9% in
Karachi (332 HIV positive among 3736 tested) and 5.3% in
Larkana (49 HIV positive out of 926 tested). We present in this
paper the baseline correlates of receptive needle sharing
among IDUs in Karachi in 1996, particularly those who con-
gregated in streets, and also assess whether HIV had entered
this group at that time.
Methods
From 1989 to 1992 the World Health Organization (WHO)
conducted a comparative study1 of drug injecting behaviors
in 13 cities (Athens, Bangkok, Berlin, Glasgow, London,
Madrid, Naples, New York, Rome, Rio de Janeiro, Santos,
Sydney and Toronto) and recruited 6390 IDUs mostly from out
of drug treatment settings. Karachi was included in phase II of
these studies since cities from less-developed countries were
not represented in phase I. Karachi is the largest city in
Pakistan. A major economic center with 9.9 million20 resi-
dents, it is divided into four districts: North, South, West, and
East.
From February through June 1996, we administered ques-
tionnaires to IDUs congregating in the streets as well as in
rehabilitation centers in Karachi, and obtained sera for HIV
testing. For comparative purposes, we used the WHO ques-
tionnaire from the New York site, which was translated into
Urdu and modified according to local settings. We estimated
that we needed a sample size of 500 IDUs based on an
estimated HIV prevalence of <1% and upper estimate of
the 95% confidence interval of 0.74. First we interviewed
key informants in each district in Karachi prior to recruiting
street IDUs to obtain a crude estimate of IDU numbers. At the
time of the study there were 26 rehabilitation centers in
Karachi.21 IDUs were selected from the streets if they had
injected at least within the last 2 months, and from the
rehabilitation centers if they had injected at least once
within the last 2 months before starting treatment. ‘Recep-
tive needle sharing’ behavior was defined as injecting with a
used needle from someone else within the last 6 months. A
‘perceived change in one’s social network’ was defined as the
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Table 1 Continuous variable risk factors associated with
receptive needle sharinga among IDUs in Karachi recruited
from February through June 1996
Risk factors Sharer Non-sharer p-Value
Mean age (years) 28 31 0.01
Mean age at first
injection (years)
25 28 0.001
Mean years of schooling 3 5 0.001
Mean monthly
income (in US$)
70 86 0.03
Mean times injected in
a day in the past 6 months
5 6 0.6
a Receptive needle sharing defined as injecting with a used
needle from someone else in the past 6 months.subject’s perception that he had either joined a new group,
or a new IDU was introduced to the group, or someone in the
group had left, injected somewhere else, and then returned
to the group within the last 6 months.
We initially chose two major privately funded rehabilita-
tion centers that provided free care (Edhi Village and Azam
Village). After an extensive search of these IDUs we did not
meet our sample size requirement and so included other
rehabilitation centers: Al-Midway Rehabilitation Center,
Asghar Hospital, and the Karachi Addiction Clinic and Sadaqat
Clinic. We also visited Karachi Central Prison to look for IDUs.
IDUs were paid an honorarium for participating in the study.
We tested blood samples for HIV-1 and HIV-2 by dipstick
test (PATH, Dipstick-HIV 1+2). We confirmed positive samples
with the same test, and re-confirmed it with ELISA (Enzyg-
nost1 Anti-HIV-1/-HIV-2; Dade Behring, Liederbach, Ger-
many) as recommended by WHO.22 We did anonymous
linked testing of the sera, provided pre-test HIV counseling,
and post-test counseling to those seeking results. The project
was reviewed and approved by the Human Subject Commit-
tee of The Aga Khan University.
Wedoubleentered thedata inEpi Info version6,23whichwe
used for analysis. We analyzed difference in continuous vari-
ables with the t-test and categorical variables with the Chi-
square test, selecting 0.05 as the level of significance. Recep-
tive needle sharing was the main outcome of interest exam-
ined in the statistical analysis. Logistic regression was used to
eliminate confounding associated with receptive needle shar-
ing using SPSS statistical software. All the significant variables
associated with receptive needle sharing were entered in the
model simultaneously and the least significant variables were
removed with backward elimination until variables with a p
value<0.05 were left. The 95% confidence interval (CI) of the
proportion of HIVamong IDUs was calculated based on Poisson
distribution.24 We also assessed for interaction between the
variable of perceived change in one’s social network and
proportion living in the North District of Karachi as receptive
needle sharing and perceived change in one’s social network
were highest in this district.
Results
After an extensive search of major injecting drug-user habi-
tats in Karachi over a period of 4 months, we found only 261
IDUs. Of these 19 (7%) refused or did not complete the
interview. Among the remaining 242 IDUs, 191 (79%) were
from the street, 40 (16%) were from rehabilitation centers,
10 (4%) were from jail and one (0.4%) was from a private
location. All were male and their mean age was 26 years. One
hundred and thirty-one (54%) were homeless and lived on the
streets. One hundred and twenty-one (50%) were from the
North District, 48 (20%) from East, 43 (18%) fromWest, and 24
(10%) from the South District. For 191 (79%) their source of
income was temporary work, followed by self-employment in
24 (10%). One hundred and sixty-five (68%) were single, 72
(30%) were married, and five (2%) were divorced or sepa-
rated. One hundred and thirty-five (56%) had been incarcer-
ated since injecting. Of the 242 IDUs interviewed 11 (4%)
refused HIV testing. Of the remaining 231, only one (0.43%;
95% CI: 0.37—0.48%) was HIV positive and was of HIV-1
serotype.Heroin was the main injecting drug that was used by 232
(96%) of the IDUs. In the preceding 6 months the major trends
among IDUs were: 169 (70%) had made a transition from non-
injecting methods to injecting, 53 (22%) had used injecting as
well as using non-injecting methods equally from the begin-
ning of use, 13 (5%) were injecting exclusively, and five (2%)
were making a transition towards sniffing heroin. Of those
who had made a transition towards injecting drugs, 145 (86%)
did so because they preferred the high rush from injection, 35
(21%) found drug quality or price to be better, 28 (17%) were
under pressure to do so from friends, 25 (15%) found it more
convenient, 13 (8%) found syringes easily available, and 13
(8%) found it easier to modulate the dose when injecting. Of
the five who had made a transition towards sniffing heroin all
cited that they preferred the high from sniffing heroin; two
said that they usually did it this way, one said that they were
satisfied with the high from sniffing, and one said that drug
quality or price was favorable. One hundred and seventy-nine
(74%) injected in each of the previous 6 months and of these
155 (87%) injected daily. Unused needles were obtained by
223 (92%) from a drug store or pharmacy.
In the past six months 114 (47%) had injected with a shared
needle. Of these, 98 (86%) obtained the shared needle from
drug injecting friends who sat together, rarely from some-
where in the street in nine (8%), from a relative in seven (6%),
and from a dealer in two (2%). The main reasons for receptive
needle sharing were: difficulty in obtaining syringes in 48
(42%), not having their own needles in 48 (42%), peer pressure
in 13 (11%), the enjoyment of sharing in 13 (11%), and ‘‘had
always shared’’ was the reason in 13 (11%).
One hundred of the 242 IDUs (41%) had self-reported a
perceived change in the social network with whom they
injected over the past six months. Receptive needle sharing
was present in 52% of IDUs who injected in the North District
of Karachi, 37.5% in the East District, 40% in the South District
and 51% in the West District, whereas perceived change in
one’s social network was present in 42% of IDUs in the North
District, 42% in the East District, 28% in the South District, and
35% in the West District of Karachi. In bivariate analysis
younger age ( p = 0.01), age at the first time of injected
drugs ( p = 0.001), fewer years of schooling ( p = 0.001), lower
monthly income ( p = 0.03), perceived change in social
network (OR = 4.4; CI = 2.4—7.9), inhaling fumes from
heroin from a foil in the year before injecting (OR = 4.8;
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Table 2 Categorical variable risk factors associated with receptive needle sharinga among IDUs in Karachi recruited from February
through June 1996
Risk factors Sharer (n = 114) Non-sharer (n = 128) Odds ratio (CI) p-Value
Having a temporary job 88% (100) 74% (95) 2.5 (1.2—5.2) 0.01
Inhaling fumes of heroin on a foil
in the year before injecting
89% (102) 64% (82) 4.8 (2.2—10.3) <0.001
When first time injected, used heroin 95% (109) 86% (110) 3.6 (1.2—12.6) 0.02
Perceived change in one’s social network
in the past 6 months
56% (29) 23% (64) 4.4 (2.4—7.9) <0.001
When first time injected had
heard about AIDS
24% (27) 33% (42) 0.6 (0.3—1.1) 0.15
When first time injected knew
that AIDS could spread by injectionb
61% (16/26) 69% (36/41) 0.2 (0.05—0.9) 0.01
a Receptive needle sharing defined as injecting with a used needle from someone else in the past 6 months.
b Total denominator = 69 (27 + 42); two excluded from analysis as they did not know/could not remember.CI = 2.2—10.3), those who when injected for the first time
used heroin (OR = 3.6; CI = 1.2—12.6), and those having a
temporary job (OR = 2.5; CI = 1.2—5.2) were associated with
receptive needle sharing (Tables 1 and 2). There was no
difference in the number of times IDUs injected between
sharers and non-sharers ( p = 0.6) (Table 1). Knowing that HIV
and AIDS could be spread by sharing contaminated needles
when they injected for first time was associated with less
receptive needle sharing (OR = 0.2; CI = 0.05—0.9) (Table 2).
In the final logistic regression model receptive needle
sharing was associated with a perceived change in one’s
social network (adjusted OR (AOR) = 4.0; CI = 2.2—7.4),
inhaling of fumes on a foil prior to injection (AOR = 5.6;
CI = 2.6—12), and inversely associated with age at the first
time of injection ( p = 0.002) (Table 3). There was no inter-
action between those living in the North District of Karachi
and those who had perceived a change in their social net-
work. The model was statistically significant ( p < 0.001).
Before injecting 188 (78%) cleaned the needle with water
only; 14 (6%) reported using heated or boiled water. None
washed the needle with bleach. One hundred and eighty-four
(76%) disposed of the needle in the garbage after using it,
while 19% gave it to someone else.
Two hundred and thirty-five (97%) had started injecting in
1996, at ages ranging between 11 and 72 years (median 25Table 3 Logistic regression analysis of risk factors asso-
ciated with receptive needle sharing among IDUs in Karachi
recruited from February through June 1996
Risk factors b Adjusted odds
ratio (CI)
p-Value
Age at first injection
(years)
0.07 0.002
Inhaling fumes of
heroin on a foil
in the year
before injecting
1.7 5.6 (2.6—12) <0.0001
Perceived change in
one’s social network
in the past 6 months
1.4 4.0 (2.2—7.4) <0.0001
Model <0.001years). When they had injected for the first time, 172 (71%)
had never heard about HIV or AIDS and 218 (90%) used heroin
at that time. The rest used morphine, buprenorphine, pethi-
dine, diazepam or pentazocine. In the year before they began
injecting, 198 (82%) were using cannabis, 184 (76%) were
inhaling fumes of heroin burnt on foil, 167 (69%) were
smoking heroin, 101 (42%) were sniffing heroin, and 75
(31%) were drinking alcohol.
One hundred and thirty (54%) were not aware of HIV. Of
the remaining 112 (46%) who knew about HIV, 42 (38%) self-
reported that they did not change their risk behavior, while
70 (63%) reported taking steps to avoid catching HIV. Most of
the IDUs who did not change their risk behavior (83% of the
42) said they had not taken steps because they were not
aware of specific measures to reduce the risk. Of the 70 who
took some measures, 32 (46%) had reduced receptive needle
sharing, 25 (36%) had increased cleaning of their needles, 20
(29%) had reduced needle use, 13 (19%) had stopped having
sex, and four (6%) had started increasing their use of con-
doms.
One hundred and eighty-eight (78%) had not had sexual
intercourse during the past six months. Of the remaining 54
who had had sex during the past six months, 36 (67%) never
used a condom, seven (13%) did so occasionally, one (2%) did
so half the time, six (11%) did so most of the time, and four
(7%) always used one. Eighteen (7%) reported male to male
sex within the last five years.
Since injecting regularly, 20 (8%) had donated their blood
for money, 11 had donated blood only when in dire need of
money, seven had donated in exchange for drugs, and two
were professional blood donors who sold blood as a regular
source of income. Only five (2%) IDUs reported that they had
traveled abroad since the start of their injecting drug use.
Two reported that they had traveled to Iran, one to India and
the other two did not mention where they had been. Of
these, three injected alone and two injected in a group but
did not respond to the question about whether they had
shared needles.
Discussion
HIV infection remained uncommon among injecting drug
users in Karachi in 1996. Nevertheless they were still at risk
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including perceived changes in their social networks, low-
level knowledge about HIV and its prevention, and wide-
spread receptive needle sharing. Later drug injecting studies
have shown that receptive needle sharing is not limited to
Karachi. In the Lahore study in 1999 it was 64% and in the 2000
national survey it was 53%, which increased among street
IDUs to 69%. In the 2001 drug injecting studies in three cities
(Quetta, Peshawar, and Rawalpindi) more than half of the
IDUs shared needles.12 In Lahore in 2001, an increase in
receptive needle sharing was observed after the 2001 Afghan
war, which was attributed to decreased availability and
increased pricing of heroin.25 Poor knowledge of HIV/AIDS
and its prevention were common to all studies. Afghani IDUs
in Quetta have been identified as another vulnerable popula-
tion in Pakistan. They were statistically significantly found to
be more likely to have injected on at least one occasion, less
likely to have heard of HIV/AIDS, and less likely to use
condoms when compared to Pakistani IDUs in Quetta.13
The low prevalence of HIV among IDUs in Pakistan at the
time of the study was not unpredictable. This is because
Pakistan was a low prevalence country for HIV26—28 and,
though HIV might have been introduced in critical numbers,
the epidemic had not yet exploded among IDUs in 1996. This
may partly be explained by the relative isolation of Pakistan
from India preventing eastward spread of HIV, social isolation
of IDUs in Karachi, and the lack of networking with other high-
risk groups. Among the reported cases of HIV in Sindh, most
were workers deported from Gulf States who acquired the
disease through sexual contact or through blood transfu-
sion.28,29 None were IDUs or commercial sex-workers. In
studies performed in Karachi in 1994, HIV was also absent
in male and female sex workers, long distance truck drivers,
and low among prisoners (0.05%), though high-risk behavior
was common.13,30
Nonetheless with the high-risk behavior, we had predicted
that HIV could spread rapidly among IDUs in Karachi, and then
to the general population. Two out of three important risk
factors for rapid spread that were identified in other cities
were present in Karachi.31 These were lack of perception of
HIV/AIDS as a local threat (most IDUs did not know about HIV
and its implications), and the other was rapid mixing which
was prevalent in all districts of Karachi. The third factor,
restriction on availability and use of new injection equip-
ment, was not present in Karachi as new injection equipment
could be easily purchased from a pharmacy. Although this is
considered complementary to a needle-exchange program,6
receptive needle sharing and the above two factors may
negate such an effect. Another risk factor, which was history
of incarceration, was prevalent among IDUs.3 There was a
lack of overlap with other HIV risk groups and across the
border networking. IDUs in our study hardly ever traveled
outside the country to other HIV endemic areas. Fortunately
we did not find in our study overlap between IDUs and sex-
workers in Karachi. This was in contrast to the Lahore study,
where sex with commercial sex workers was prevalent (50%)
among IDUs. This may be explained by the fact that IDUs in
Karachi were homeless, socially ostracized, and solely used
heroin which decreases libido.32 In Karachi, IDUs were at risk
of infecting their spouses as few used protective contra-
ception. Another means by which HIV could be spread to
the general population would be by IDUs who are professionalblood donors, as 45% of blood banks in Karachi do not screen
for HIV33 and syringes are commonly re-used without being
disinfected in clinical settings.34 In our study the fact that
fewer IDUs (8%) donated blood for money as compared to the
previous study in Karachi (26%) might be due to the higher
number of socially ostracized street IDUs in our study.
Multivariate analysis showed that those who shared nee-
dles were more likely to be young, were more likely to have
perceived a change in the social network in which they inject
in the past 6 months, and were using heroin with panee prior
to injecting. This suggested a sub-group of IDUs who were
young and changing groups and hence were more prone to
acquire and transmit HIV. Comparing IDUs with a cohort of
non-IDUs from a part of the same study has identified income
generation via illegal modes, non-sharing of income with
family and presence of suicidal thoughts as risk factors for
injecting.35 A case-control study done in Lahore has identi-
fied a number of risk factors for heroin drug addiction.36
Hence interventions to reduce drug demand and also to
prevent addiction should be focused on those who inhale
heroin and populations susceptible to drug addiction.
This trend from non-injectable to injectable forms of
heroin in Karachi in 1996 was consistent with the trend of
opium smoking to eventual heroin injecting seen in other
Southeast Asian countries, partly due to the addictive nature
of heroin itself, which was also the most common reason
identified by IDUs for shifting to injecting heroin in our study.
Unfortunately only few IDUs (five) were making a transition
towards sniffing heroin. Now the injecting route for heroin is
prevalent in all major cities in Pakistan, particularly in
Karachi as seen in subsequent surveys.17 This may be due
to the availability of heroin, as in other cities drug users have
made a transition to injecting other substances like bupre-
norphine.37
In univariate analysis other variables that have public
health implications were not significant in the multivariable
analysis but were associated with receptive needle sharing.
These were fewer years of schooling, a low monthly income,
and decreased receptive needle sharing among those who
had heard about AIDS. HIV/AIDS education has been shown to
diminish sharing and reduce HIV incidence among IDUs in
Bangkok.38 Various health belief models and constructs have
been identified or applied gearing IDUs towards a positive
behavior change among IDUs including out-reach HIV/AIDS
education,39—41 a media education campaign,42 and high
perceived self-efficacy for risk reduction.43 Educating IDUs
in Karachi based on these health belief models about risk of
acquiring HIV/AIDS through sharing could be an effective low
cost intervention.
To further curb HIV from spreading among existing IDUs in
Pakistan, well-proven interventions31 would be (a) an HIV/
AIDS education program,39—40 preferably a community-based
outreach program, (b) a needle exchange program (NEP),44,45
and (c) a methadone maintenance program.46
Free availability of needles in pharmacies in Pakistan
could act as a surrogate to a needle exchange program.6
An advantage of a formal needle exchange program is that it
provides community outreach and education6 and is calcu-
lated to be a cost-effective strategy for HIV prevention.47
Newer and innovative strategies include obtaining clean
needles through a physician’s prescription,48,49 purcha-
sing them through a pharmacy without prescription,50 and
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exchange new syringes.51
Currently there are 10 drop-in centers in Pakistan provid-
ing harm reduction services including needle exchange at
non-governmental drug detoxification centers and two
mobile vans (personal communication: Rehman N; Program
Coordinator United Nations Office of Drug Control, Pakistan).
The first program was started in Lahore in 2000, and in 2001
three harm reduction drop-in centers were opened in Kar-
achi. These programs need to be expanded in Karachi and in
other cities of Pakistan where injecting drug use is a problem.
Unfortunately methadone is prohibited by law in Pakistan.
However, although there is a lack of long-term studies on
alternatives to methadone, evaluating reduction in injecting
drug use and HIV incidence, sublingual buprenorphine is a
promising alternative.52 This has been implemented success-
fully in neighboring India in drug rehabilitation centers53 and
drug demand/harm reduction programs.54 The harm reduc-
tion centers in Pakistan provide detoxification services and
no drug demand reduction with sublingual buprenorphine or
methadone. Pakistan can follow India’s strategy.
From the studies prior to the HIV outbreak in Karachi in
2003 at the drop-in centers where an NEP was available,
receptive needle sharing (HCV prevalence = 86—94%) and
drug injecting in groups (80%) was common among IDUs.17
Also they had a high prevalence of syphilis (13%) and hepatitis
B (7.5%). A good aspect was that 90% of IDUs claimed that
they usually used a new needle. The failure of harm reduction
programs in preventing this outbreak of HIV among Karachi
IDUs has been attributed to a number of flaws/gaps in these
programs (e.g., lack of advocacy, lack of coordination with
HIV/AIDS programs, lack of drug treatment and an enabling
environment for IDUs).19 Although a systemic analysis is
needed to evaluate the exact reasons for the HIV outbreak
among IDUs in Karachi, the most likely reason would be IDUs
changing groups and needle sharing, which transmitted and
propagated a virulent strain of HIV from the Larkana outbreak
(as one IDU from the drop-in center in Karachi was identified
to be HIV positive from the Larkana outbreak prior to the HIV
epidemic in Karachi). We speculate that the HIV epidemic in
Karachi could have been worse if the needle exchange
program was not in place.
Active surveillance of HIV needs to be continued to find the
exact estimates of HIV prevalence and to motivate drug
addicts to participate in drug demand/risk reduction pro-
grams. To have effective HIV control among IDUs in Pakistan,
HIV surveillance and IDU harm reduction/risk drug reduction
programs need to be coordinated, and have long-term com-
mitment and funding. Their effectiveness as well as determi-
nants of IDU risk behavior need to be evaluated on a continual
basis in order to develop more effective interventions.55 Gaps
in HIV surveillance and program evaluations can lead to a false
sense of security aswas seen inNepal,whereHIVrose from0 to
50%among IDUs in a surveillance-freeperiod from1994 to1999
despite a needle exchange program.56
This study has important limitations. Firstly, these data do
not reflect the current situation in Karachi, however they do
serve as a background for comparison. Secondly, we did not
find a sufficient number of IDUs as projected by the National
surveys.11 This could be due to a number of reasons: (1)
overestimates from the NSDA 1993 survey as there was a
decrease of 67% of heroin addicts in the 2002 estimate, (2) wemissed ‘home addicts’ as the national surveys were based on
household surveys, and (3) we did not find any females in the
study as heroin users are mostly males in Pakistan, though
newer surveys have identified a small number of females.57
These make our study less representative. However, our
study was more representative than other studies13,14 that
were based on convenience sampling. Our study was more
systemic in approach and focused on destitute street addicts
who are at the highest risk of acquiring HIV and receptive
needle sharing,1 as confirmed by the national survey of 2000.
Also, in our study 4% (n = 11) of IDUs refused or could not be
tested for HIV, which may have affected the prevalence
estimate. Our low prevalence of HIV was consistent with
prior13 and subsequent studies14,17 of HIV prevalence among
IDUs in Pakistan. Lastly, because of the cross-sectional nature
of the study a cause—effect relationship between the vari-
ables associated with receptive needle sharing cannot be
ascertained.
In conclusion despite the low background HIV prevalence
among IDUs in Karachi in 1996, injecting behavior was risky
enough for easy HIV transmission as we are seeing in the
current HIVepidemic. Drug demand interventions are needed
to prevent drug users shifting towards injecting. HIV surveil-
lance needs to be done on a continual basis in all places
where injecting drug use is a problem. To keep HIV preva-
lence from further increasing among IDUs in Karachi, well-
coordinated HIV risk reduction and demand reduction pro-
grams need to be continued and expanded. These programs
need to be evaluated on a continual basis for effectiveness
and coordinated with HIV surveillance and risk behavior
studies. Efforts need to be prioritized to areas that are
undergoing an HIV epidemic or are most vulnerable.
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